This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
AOD 9604 vs CJC-1295/Ipamorelin Growth hormone releasing peptides work by increasing your body's natural GH production
Understanding legality helps users stay compliant and avoid unnecessary purchasing risks
Or bought in a bundle of 6 injections at 180, then works out to be 30 each
Inspect and store: Ensure a clear solution, label the vial with date, concentration, and peptide name